Drug coverage policies and clinical guidelines alignment: Most coverage decisions include additional restrictions
Frontiers in Pharmacology
Value attribution for oncology combination regimens: going beyond frameworks to balance innovation, access, and affordability
Value in Health
Health utilities in Alzheimer's disease: A survey of patients and caregivers in the United States
Value in Health
US Drug Pricing Patterns Before Loss of Exclusivity
Health Affairs Scholar
An analysis of US net cancer drug launch prices and clinical efficacy and certainty of evidence from 2008 to 2022
JMCP
Assessing variation in US payer coverage of anti–vascular endothelial growth factor therapies for the treatment of age-related macular degeneration, diabetic retinopathy, and diabetic macular edema
Health Affairs Forefront
Bringing Systems Thinking To Drug Value Assessment
Health Affairs Forefront
Medicare Coverage Of Medical Technologies In A New Era
JMCP
Use of health technology assessments in specialty drug coverage decisions by US commercial health plans
